FDA Inspection 1245572 — Dr. Fausto Meriggi
The FDA completed an inspection of Dr. Fausto Meriggi on Aug 2, 2024 in Brescia. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 2, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brescia (Italy)
Additional Details
Clinical Investigator (CI)